BBIO Key Financial Ratios - BridgeBio Pharma, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	1.23	—	-57.67%	27.91%
2026-03-31	1.52	—	-53.24%	32.04%
2025-12-31	2.77	—	-78.30%	35.13%
2025-09-30	3.88	—	-80.71%	41.68%
2025-06-30	5.19	—	-72.67%	43.91%
2025-03-31	4.57	—	-76.77%	41.06%
2024-12-31	4.67	—	-59.10%	37.02%
2024-09-30	3.19	—	-67.11%	36.29%
2024-06-30	4.59	—	-58.10%	42.23%
2024-03-31	5.54	—	-64.37%	52.09%
2023-12-31	3.32	—	-119.56%	48.24%
2023-09-30	5.54	—	-95.19%	51.63%
2023-06-30	3.93	—	-115.99%	42.89%
2023-03-31	5.72	—	-68.09%	34.76%
2022-12-31	4.52	—	-77.79%	38.63%
2022-09-30	5.39	—	-68.11%	43.60%
2022-06-30	5.46	—	-59.98%	50.43%
2022-03-31	6.92	—	-75.84%	59.24%
2021-12-31	6.58	—	-57.90%	67.38%
2021-09-30	6.68	—	-72.83%	76.57%
2021-06-30	6.9	—	-49.78%	115.95%
2021-03-31	9.98	-0.24	-52.36%	144.83%
2020-12-31	6.72	1.62	-71.84%	-872.95%
2020-09-30	9.85	—	-57.71%	-277.62%
2020-06-30	9.3	—	-42.54%	-144.91%
2020-03-31	14.25	—	-32.66%	-84.90%
2019-12-31	9.42	—	-45.69%	-70.65%
2019-09-30	14	—	-39.60%	-55.18%
2019-06-30	—	—	—	-144.29%
2018-12-31	13.67	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	2.77	—	-78.30%	35.13%
2024-12-31	4.67	—	-59.10%	37.02%
2023-12-31	3.32	—	-119.56%	48.24%
2022-12-31	4.52	—	-77.79%	38.63%
2021-12-31	6.58	—	-57.90%	67.38%
2020-12-31	6.72	1.62	-71.84%	-872.95%
2019-12-31	9.42	—	-45.69%	-70.65%
2018-12-31	13.67	—	-36.45%	-53.81%
2017-12-31	—	—	—	-51.06%